vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and MERCANTILE BANK CORP (MBWM). Click either name above to swap in a different company.

Core Laboratories Inc. is the larger business by last-quarter revenue ($121.8M vs $67.6M, roughly 1.8× MERCANTILE BANK CORP). MERCANTILE BANK CORP runs the higher net margin — 33.6% vs 4.2%, a 29.4% gap on every dollar of revenue. Over the past eight quarters, MERCANTILE BANK CORP's revenue compounded faster (9.1% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Tamilnad Mercantile Bank Limited (TMB) is an Indian bank headquartered at Thoothukudi, Tamil Nadu. TMB was founded in 1921 as the Nadar Bank, but changed its name to Tamilnad Mercantile Bank in November 1962 to widen its appeal beyond the Nadar community. The bank currently has 600 full branches throughout India, 12 regional offices and two link offices, two central processing centres, one service branch, four currency chests, 48 eLobby centres, 262 cash recycler machines and 1151 automated ...

CLB vs MBWM — Head-to-Head

Bigger by revenue
CLB
CLB
1.8× larger
CLB
$121.8M
$67.6M
MBWM
Higher net margin
MBWM
MBWM
29.4% more per $
MBWM
33.6%
4.2%
CLB
Faster 2-yr revenue CAGR
MBWM
MBWM
Annualised
MBWM
9.1%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
MBWM
MBWM
Revenue
$121.8M
$67.6M
Net Profit
$5.1M
$22.7M
Gross Margin
Operating Margin
1.5%
Net Margin
4.2%
33.6%
Revenue YoY
-1.4%
Net Profit YoY
16.1%
EPS (diluted)
$0.11
$1.32

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
MBWM
MBWM
Q1 26
$121.8M
$67.6M
Q4 25
$138.3M
$62.1M
Q3 25
$134.5M
$62.4M
Q2 25
$130.2M
$60.9M
Q1 25
$123.6M
$57.3M
Q4 24
$129.2M
$58.5M
Q3 24
$134.4M
$58.0M
Q2 24
$130.6M
$56.8M
Net Profit
CLB
CLB
MBWM
MBWM
Q1 26
$5.1M
$22.7M
Q4 25
$4.9M
$22.8M
Q3 25
$14.2M
$23.8M
Q2 25
$10.6M
$22.6M
Q1 25
$-154.0K
$19.5M
Q4 24
$7.4M
$19.6M
Q3 24
$11.7M
$19.6M
Q2 24
$9.0M
$18.8M
Gross Margin
CLB
CLB
MBWM
MBWM
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
MBWM
MBWM
Q1 26
1.5%
Q4 25
11.5%
42.0%
Q3 25
15.6%
44.0%
Q2 25
11.7%
42.6%
Q1 25
3.6%
42.0%
Q4 24
11.0%
39.7%
Q3 24
14.7%
42.4%
Q2 24
12.3%
41.4%
Net Margin
CLB
CLB
MBWM
MBWM
Q1 26
4.2%
33.6%
Q4 25
3.6%
36.8%
Q3 25
10.6%
38.1%
Q2 25
8.2%
37.1%
Q1 25
-0.1%
34.1%
Q4 24
5.7%
33.5%
Q3 24
8.7%
33.8%
Q2 24
6.9%
33.1%
EPS (diluted)
CLB
CLB
MBWM
MBWM
Q1 26
$0.11
$1.32
Q4 25
$0.11
$1.41
Q3 25
$0.30
$1.46
Q2 25
$0.22
$1.39
Q1 25
$0.00
$1.21
Q4 24
$0.15
$1.20
Q3 24
$0.25
$1.22
Q2 24
$0.19
$1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
MBWM
MBWM
Cash + ST InvestmentsLiquidity on hand
$22.8M
Total DebtLower is stronger
$1.5M
Stockholders' EquityBook value
$275.1M
$736.9M
Total Assets
$587.7M
$6.9B
Debt / EquityLower = less leverage
0.00×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
MBWM
MBWM
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$25.6M
Q2 25
$31.2M
Q1 25
$22.1M
Q4 24
$19.2M
Q3 24
$21.5M
Q2 24
$17.7M
Total Debt
CLB
CLB
MBWM
MBWM
Q1 26
$1.5M
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
MBWM
MBWM
Q1 26
$275.1M
$736.9M
Q4 25
$266.0M
$724.9M
Q3 25
$271.3M
$657.6M
Q2 25
$261.3M
$631.5M
Q1 25
$253.4M
$608.3M
Q4 24
$246.6M
$584.5M
Q3 24
$250.7M
$583.3M
Q2 24
$240.3M
$551.2M
Total Assets
CLB
CLB
MBWM
MBWM
Q1 26
$587.7M
$6.9B
Q4 25
$584.0M
$6.8B
Q3 25
$591.4M
$6.3B
Q2 25
$602.1M
$6.2B
Q1 25
$591.5M
$6.1B
Q4 24
$585.1M
$6.1B
Q3 24
$600.5M
$5.9B
Q2 24
$597.8M
$5.6B
Debt / Equity
CLB
CLB
MBWM
MBWM
Q1 26
0.00×
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
MBWM
MBWM
Operating Cash FlowLast quarter
$4.0M
Free Cash FlowOCF − Capex
$517.0K
FCF MarginFCF / Revenue
0.4%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
MBWM
MBWM
Q1 26
$4.0M
Q4 25
$7.9M
$18.0M
Q3 25
$8.5M
$23.1M
Q2 25
$13.9M
$-7.8M
Q1 25
$6.7M
$-3.0M
Q4 24
$20.6M
$101.1M
Q3 24
$13.1M
$-8.1M
Q2 24
$17.1M
$9.1M
Free Cash Flow
CLB
CLB
MBWM
MBWM
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$6.5M
Q2 25
$10.4M
Q1 25
$3.9M
Q4 24
$17.4M
Q3 24
$10.4M
Q2 24
$14.3M
FCF Margin
CLB
CLB
MBWM
MBWM
Q1 26
0.4%
Q4 25
3.6%
Q3 25
4.8%
Q2 25
8.0%
Q1 25
3.1%
Q4 24
13.4%
Q3 24
7.7%
Q2 24
10.9%
Capex Intensity
CLB
CLB
MBWM
MBWM
Q1 26
Q4 25
2.1%
Q3 25
1.5%
Q2 25
2.7%
Q1 25
2.3%
Q4 24
2.5%
Q3 24
2.0%
Q2 24
2.2%
Cash Conversion
CLB
CLB
MBWM
MBWM
Q1 26
0.77×
Q4 25
1.61×
0.79×
Q3 25
0.60×
0.97×
Q2 25
1.31×
-0.35×
Q1 25
-0.15×
Q4 24
2.78×
5.15×
Q3 24
1.12×
-0.41×
Q2 24
1.90×
0.49×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

MBWM
MBWM

Net Interest Income$55.9M83%
Noninterest Income$11.7M17%

Related Comparisons